6130.TWO · SHANGYA
Taiwan · RS rating 6 · As of 2026-10-08
| Price | 23.00 TWD |
|---|---|
| 1-day change | +0.7% |
| RS rating (overall / 1M / 3M / 12M) | 6 / 4 / 23 / 5 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 38 / 5 / 44 |
| Industry group (rank) | Medical-Biomed/Biotech (53) |
| EPS growth Q/Q | +183.9% |
| Sales growth Q/Q | +26.2% |
| Distance from 52-week high | +51.3% |
| Market cap (USD) | $36.4M |